InvestorsHub Logo
Followers 45
Posts 3487
Boards Moderated 0
Alias Born 05/26/2011

Re: StockPanzer post# 50524

Tuesday, 01/04/2022 9:06:02 PM

Tuesday, January 04, 2022 9:06:02 PM

Post# of 50662
RGBP.. The Biopaharma area is one of the toughest of all to either invest in, or to develop, as the costs are tremendous and the ?employees? or team members are taking off faster than Usane Bolt! I thought mcet had a chance, so I decided upon two stocks MCET or RGBP to buy into! I can't call it luck yet as rgbp still has a way to go, but still is trading at least!


I like the genre because I did well with one of my picks, so I was an early buyer of RGBP when it was a youngster under the tutelage of BioMatrix! I sold out after Biomatrix left town, but bought right back in when I saw that rgbp Had found a place to continue their work! It is going anywhere now as far as the PPS goes, but they have patents of a high order, with some in the lengthy clinical trial phase! Once the GENERAL CANCER Vaccine finishes-up in its clinical trial, it should start to see some revenue?

MCET did OK for a while, but it started to stall some time ago for reasons unknown to me, so I didn't buy in just because it drifted to cheap Man's land! Just because it was a BioPharma co' was of no value to me, only results mattered! I wish them well and hope they can resurrect some of those promising Treatments or Vaccines, as they show hope? Look up (BRCHF) Artificial Intelligence Stock, you might like it? But don't buy in until you know all the facts, and there are many! Gl in 2022!